The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: September 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next

Houlahan, K., E. et al. Science. 384: 6699 (2024).
doi: 10.1126/science.adh8697.

Summary and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

Cancer cells have the ability to hijack various cellular processes and hence despite presenting similar clinical characteristics tumours may present molecular differences with serious implications for disease prognostic and treatment response. The germline genome is highly variable, with differences across individuals occurring at millions of polymorphic sites. This variability may play a role in dictating the somatic evolution of the tumour. Mounting evidence suggests that a subset of T cells may respond to germline-derived epitopes during tumorigenesis.

In this paper, Houlahan et al investigated the role that germline variability may play in the development of various types of breast cancer by mediating immunoediting. Starting from the hypothesis that during tumour progression the body would select against genomic amplifications of germline variants that produce MHC class I antigenic determinants, the authors show that germline-derived epitopes have the ability to influence the molecular subtype that breast tumours commit to. The authors of this paper suggest that this germline-derived epitope burden negative selection is likely to occur beginning from precancerous lesions and persists throughout tumour progression influencing the metastatic predisposition. When tumours develop despite a high germline-derived epitope burden, they develop immune evasion mechanisms and hence tend to be more aggressive.

.

Future impact

Understanding how genome-mediated immunoediting determines the subtype of cancer developed by a patient has important clinical implications as germline variants could potentially be used as blood biomarkers that could identify tumours with high lymphocyte infiltration and could inform the risk of relapse.
.
Read more in Science

4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026

EACR member Amel Aziba has now completed her EACR-Molecular Oncology Editorial Fellowship, funding that is awarded to enable a talented cancer researcher to gain knowledge and...

“Broadened my scientific network, strengthened my research skills, and opened new possibilities for my future career” – Pilar Salamanca Jiménez’s Travel Fellowship

“Broadened my scientific network, strengthened my research skills, and opened new possibilities for my future career” – Pilar Salamanca Jiménez’s Travel Fellowship

August 11, 2026

Pilar Salamanca Jiménez is a PhD Candidate at the Bellvitge Biomedical Research Institute (IDIBELL), at the University of Barcelona, Spain, who received an EACR Travel Fellowship...

“A fantastic opportunity to structure my project, network, and try to obtain my first grant” – Patrycja Fryzik’s Travel Fellowship

“A fantastic opportunity to structure my project, network, and try to obtain my first grant” – Patrycja Fryzik’s Travel Fellowship

August 10, 2026

Patrycja Fryzik is a PhD student at the Princess Maxima Center for Pediatric Oncology, The Netherlands, who received an EACR Travel Fellowship to visit and work...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team
Career

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026
“Broadened my scientific network, strengthened my research skills, and opened new possibilities for my future career” – Pilar Salamanca Jiménez’s Travel Fellowship
Career

“Broadened my scientific network, strengthened my research skills, and opened new possibilities for my future career” – Pilar Salamanca Jiménez’s Travel Fellowship

August 11, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR